The groundbreaking approach of the medication represents a major development in the handling of the condition. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide788538.theideasblog.com/42496462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment